Cyteir Therapeutics
Cyteir Therapeutics is a rapid destruction of cancer cells founded in 2012 by Tim Romberger.
8
Funding Rounds
$253.1m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti* Ro******* | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti***** Ro******* | - | - | - |
| Su*** M. Mo******* | - | - | |
| Je** Ge**** | - | - | - |
| Ma**** Re******* | - | - | - |
| Ra***** Br***** | - | - | - |
| Jo**** S. Za******** | - | - | - |
| Jo** Th*** | - | - | - |
| Je***** Hu****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cyteir Therapeutics has raised a total of $69.2m in funding over 8 rounds.
Key Insights:
- Cyteir Therapeutics , October 2019: $40.2m
- Cyteir Series B round, March 2018: $29m
- Cyteir Therapeutics funding round, March 2018: $29m
- Cyteir Therapeutics funding round, October 2019: $40.2m
- Cyteir Therapeutics Series C round February 2021: $80m
- Cyteir Therapeutics, Inc. funding round, March 2018: $29m
- Cyteir Therapeutics, Inc. funding round, December 2015: $5.72m
Cyteir Therapeutics , October 2019
$40.2m
Cyteir Series B round, March 2018
$29m
Cyteir Therapeutics funding round, March 2018
$29m
Cyteir Therapeutics funding round, October 2019
$40.2m
Cyteir Therapeutics Series C round February 2021
$80m
Cyteir Therapeutics, Inc. funding round, March 2018
$29m
Cyteir Therapeutics, Inc. funding round, December 2015
$5.72m
Industries
Cyteir Therapeutics is active in the following industries:
- Biomedical engineering
- Biology
- Synthetic chemistry
- Engineering
- Oncology
- Biotechnology
- Technology